Altria’s Dividend Yield Signals Doubts About the Payout. Why It’s Safe.
[ad_1] The FDA’s bid to ban Juul products—like these at a shop in El [more…]
[ad_1] The FDA’s bid to ban Juul products—like these at a shop in El [more…]
[ad_1] Text size Rising macroeconomic uncertainty contributed to a downgrade of Altria’s stock in [more…]
[ad_1] Text size Juul can appeal the FDA ban if it chooses. Mario Tama/Getty [more…]
[ad_1] Juul Labs was on pace to make 94% of its revenue in the [more…]
[ad_1] Text size Analyst Pamela Kaufman lowered her price target to $50 from $54. [more…]